# Nuclide record sinotau-pharmaceutical (company). Data CC BY-NC 4.0, attribute "Data from Nuclide (nuclide.cc)". Whole corpus: https://nuclide.cc/api/v1/nuclide.nt
@prefix schema: <https://schema.org/> .
@prefix nuclide: <https://nuclide.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://nuclide.cc/companies/sinotau-pharmaceutical/>
  a schema:Organization ;
  nuclide:kind "company" ;
  schema:identifier "sinotau-pharmaceutical" ;
  schema:name "Sinotau Pharmaceutical"@en ;
  schema:alternateName "Sinotau Pharmaceutical Group"@en ;
  schema:description "Sinotau Pharmaceutical is a China-based radiopharmaceutical company running 2 late-stage cancer trials of Octreotide LAR in neuroendocrine tumours."@en ;
  schema:url <https://nuclide.cc/companies/sinotau-pharmaceutical/>, <https://www.sinotau.com/> ;
  schema:dateModified "2026-09-11"^^xsd:date ;
  schema:citation <https://www.sinotau.com/>, <https://clinicaltrials.gov/search?lead=Sinotau%20Pharmaceutical%20Group> ;
  nuclide:tag "ctgov-sponsor" ;
  schema:addressCountry "CN" ;
  nuclide:related <https://nuclide.cc/isotopes/lu-177/> ;
  nuclide:indications <https://nuclide.cc/indications/neuroendocrine/> ;
  nuclide:trials <https://nuclide.cc/trials/nct05459844/>, <https://nuclide.cc/trials/nct06398444/> .